Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177927 | SCV000229888 | uncertain significance | not provided | 2014-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000685344 | SCV000812822 | uncertain significance | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-08-16 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 197022). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. This variant has not been reported in the literature in individuals affected with FBN1-related conditions. This variant is present in population databases (rs794727601, gnomAD no frequency). This sequence change affects codon 1582 of the FBN1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the FBN1 protein. It affects a nucleotide within the consensus splice site. |
Color Diagnostics, |
RCV001185487 | SCV001351710 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-02-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996571 | SCV004814696 | likely benign | Marfan syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |